HR vs DOC Stock Comparison

Healthcare Realty Trust and Healthpeak Properties Prices as of Nov 13, 2026 Peers: Industry group

Head to Head

7 decided of 12

Healthpeak Properties leads on 5 of the 12 questions below (Healthpeak Properties 5, Healthcare Realty Trust 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionHRDOCLeader
Larger companyMarket capitalisation $6.62B $13.75B DOC
Cheaper on earningsLower P/E, profitable companies only -56.5x 36.5x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — –
Faster revenue growthRevenue growth, trailing twelve months -4.9% +9.4% DOC
More profitableNet margin, trailing twelve months -10.2% 12.3% DOC
Better return on capitalReturn on invested capital — -7.1% –
Less leveragedLower net debt / EBITDA — -962.8x –
Higher dividend yieldTrailing dividend yield 0.05% -0.06% –
Better 1-year returnPrice return, last 12 months +6.9% +14.2% DOC
Better 5-year returnAnnualised price return, 5 years -9.7%/yr -10.0%/yr HR
Less volatileAnnualised volatility, 1 year 20.3% 28.6% HR
Higher overall scoreMean of the five percentile scores vs peers 38/100 46/100 DOC

Percentile Scorecard

HRDOC

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisHRDOC
Valuation 27 #109 of 149 34 #99 of 149
Growth 32 #100 of 147 45 #82 of 147
Profitability 30 #101 of 144 43 #83 of 144
Financial Health 43 #86 of 149 58 #63 of 149
Shareholder Returns 57 #60 of 139 50 #70 of 139
Overall 38 46
  • HR ranked among 150 companies in Property REITs
  • DOC ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodHRDOCSPY
1 month +13.4%+6.7% -2.0%
3 months +0.4%-3.8% -2.8%
6 months -4.8%+3.3% +2.0%
Year to date +14.0%+24.3% +10.6%
1 year +6.9%+14.2% +12.2%
3 years +31.1%+18.0% +68.1%
3 years, per year +9.4%+5.7% +18.9%
5 years -39.9%-40.9% +61.4%
5 years, per year -9.7%-10.0% +10.1%
10 years -30.9%-28.9% +248.5%
10 years, per year -3.6%-3.3% +13.3%

Risk

MeasureHRDOCSPY
Volatility, 1Y 20.3%28.6% 13.6%
Downside volatility, 1Y 19.8%24.1% 13.9%
Beta vs S&P 500, 1Y 0.110.34 1.00
Return / volatility, 1Y 0.340.49 0.90
Max drawdown, 5Y -60.6%-57.6% -25.4%
From 52-week high -11.7%-12.4% -3.2%
52-week high $21.89$22.83 $779.14
52-week low $16.34$15.78 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleHRDOC
P/E now vs peer median -56.2xmedian 26.1x 36.5xmedian 26.1x
P/S now vs peer median 5.7xmedian 4.3x 4.5xmedian 4.3x
EV/EBITDA now vs peer median —median 14.5x -3,321xmedian 14.5x
P/FCF now vs peer median 72.1xmedian 21.4x -6.0xmedian 21.4x
P/B now vs peer median 1.6xmedian 1.2x 1.3xmedian 1.2x
PEG now vs peer median -2.57median 1.75 4.77median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsHRDOC
Revenue $1.15B $3.06B
Gross profit – $1.74B
Operating income – -$1.20B
Net income -$118.41M $443.23M
Free cash flow $91.11M -$2.30B
EPS (diluted) $-0.34 $0.55
Cash & equivalents $17.50M $514.31M
Total debt $4.25B $6.14B
Shares (diluted) 340.62M 689.51M
Enterprise value $6.53B $9.97B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricHRDOC
P/E -56.2x 36.5x
P/FCF 72.1x -6.0x
P/Operating cash flow 18.0x 10.8x
P/S 5.7x 4.5x
P/B 1.6x 1.3x
P/Tangible book 1.8x 1.4x
EV/EBITDA – -3,321x
EV/EBIT – -16.2x
EV/Revenue 9.4x 6.3x
EV/FCF 118.5x -8.4x
EV/Operating cash flow 29.6x 15.3x
PEG (3Y EPS CAGR) -2.57 4.77

Growth

14 metrics
MetricHRDOC
Revenue growth (1Y) -4.9% 9.4%
Revenue CAGR (3Y) -5.4% 12.5%
Gross profit growth (1Y) – 3.4%
Gross profit CAGR (3Y) – 11.6%
Operating income growth (1Y) – -83.3%
Operating income CAGR (3Y) – -92.0%
Net income growth (1Y) 68.2% 2,652%
Net income CAGR (3Y) 24.6% 17.9%
EPS growth (1Y) 67.3% 1,076%
EPS CAGR (3Y) 21.9% 7.7%
Operating cash flow growth (1Y) – 2.3%
Operating cash flow CAGR (3Y) -11.0% 10.9%
Free cash flow growth (1Y) – -787.4%
Free cash flow CAGR (3Y) -18.9% -326.3%

Profitability

14 metrics
MetricHRDOC
Gross margin – 56.8%
EBITDA margin – -0.2%
Operating margin – -39.2%
Pretax margin – 13.5%
Net margin -10.2% 12.3%
FCF margin 8.0% -75.1%
Operating cash flow margin 31.9% 41.5%
Return on equity -2.8% 4.2%
Return on assets -1.3% 1.9%
Return on invested capital – -7.1%
Return on capital employed – –
Asset turnover 0.1x 0.1x
Cash conversion (OCF / net income) -3.1x 2.9x
Stock comp / revenue 1.5% 0.6%

Financial Health

11 metrics
MetricHRDOC
Debt / assets 47.4% 27.4%
Debt / equity 1.0x 0.6x
Net debt / EBITDA – -962.8x
Debt / FCF 46.6x -2.7x
Liabilities / assets 53.9% 51.9%
Equity / assets 46.1% 48.1%
Interest coverage – -14.7x
Current ratio – –
Quick ratio – –
Cash ratio – –
Altman Z-score – –

Shareholder Returns

7 metrics
MetricHRDOC
Dividend yield 5.0% 6.5%
Net buyback yield 3.5% 0.7%
Shareholder yield 8.4% 7.3%
Payout ratio (earnings) -301.7% 190.5%
Payout ratio (FCF) 392.1% -36.7%
Dividend growth (1Y) – 0.3%
Dividend CAGR (3Y) -8.9% -8.9%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusHRDOC
EPS, next fiscal year $-0.13FY2026 –
Revenue, next fiscal year $1.17BFY2026 $2.86BFY2026
Revenue growth, next FY -0.7%FY2026 +3.7%FY2026
Revenue growth, the year after -8.1% +12.9%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersHRDOC
Held by institutions 100.0% 95.7%
Institutions holding 460 761
Change in shares held, QoQ +0.8% -2.9%
Institutions buying 226 341
Institutions selling 146 314
Buyers to sellers 1.55 1.09

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

HRDOC
HR 1.00 0.57
DOC 0.57 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, HR and DOC?

Healthpeak Properties (DOC) is the largest by market capitalisation: Healthcare Realty Trust (HR) $6.62B, Healthpeak Properties (DOC) $13.75B.

Which company is growing faster?

Healthpeak Properties (DOC) grew revenue fastest over the trailing twelve months: Healthcare Realty Trust (HR) -4.9%, Healthpeak Properties (DOC) +9.4%.

Which company is more profitable?

Healthpeak Properties (DOC) has the highest net margin (Healthcare Realty Trust (HR) -10.2%, Healthpeak Properties (DOC) 12.3%).

Which stock has performed better?

Over the past year Healthpeak Properties (DOC) returned the most: Healthcare Realty Trust (HR) +6.9%, Healthpeak Properties (DOC) +14.2%. Over five years, Healthcare Realty Trust (HR) compounded fastest (Healthcare Realty Trust (HR) -9.7%/yr, Healthpeak Properties (DOC) -10.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Healthcare Realty Trust (HR) 0.05%, Healthpeak Properties (DOC) -0.06%. Healthpeak Properties (DOC) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Healthcare Realty Trust (HR) has been the steadiest (Healthcare Realty Trust (HR) 20.3%, Healthpeak Properties (DOC) 28.6%). Volatility measures how widely the price swings, not the risk of the business.

Do HR and DOC move together?

Their daily returns over the past year have a correlation of 0.57, a moderate positive relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, HR and DOC?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Healthpeak Properties (DOC) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.